About MicroTransponder
MicroTransponder is a company based in Dallas (United States) founded in 2007 by Navzer Engineer and Jordan Curnes. MicroTransponder has raised $180.45 million across 25 funding rounds from investors including HHS, USVP and Osage University Partners. The company has 33 employees as of December 31, 2022. MicroTransponder offers products and services including Vivistim Paired VNS System. MicroTransponder operates in a competitive market with competitors including Conformal Medical, Perfuze, MIVI Neuroscience, Wallaby Medical and Enspire DBS Therapy, among others.
- Headquarter Dallas, United States
- Employees 33 as on 31 Dec, 2022
- Founders Navzer Engineer, Jordan Curnes
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$180.45 M (USD)
in 25 rounds
-
Latest Funding Round
$65 M (USD), Series F
Mar 05, 2025
-
Investors
HHS
& 10 more
-
Employee Count
33
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MicroTransponder
MicroTransponder offers a comprehensive portfolio of products and services, including Vivistim Paired VNS System.
Stimulates vagus nerve during therapy to aid stroke patient motor recovery.
People of MicroTransponder
Unlock access to complete
Funding Insights of MicroTransponder
MicroTransponder has successfully raised a total of $180.45M across 25 strategic funding rounds. The most recent funding activity was a Series F round of $65 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MicroTransponder
MicroTransponder has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, USVP and Osage University Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked | |
|
Early- to growth-stage startups are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are pursued.
|
Locked | Locked | Locked |
Investor details for MicroTransponder
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MicroTransponder
Investment portfolio details for MicroTransponder
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MicroTransponder
Detailed financials for MicroTransponder
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microtransponder Comparisons
Peer comparison for MicroTransponder
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MicroTransponder
MicroTransponder operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, Perfuze, MIVI Neuroscience, Wallaby Medical and Enspire DBS Therapy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| Locked | Locked | Locked |
A medical device for acute ischemic stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
A medical device for stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Stroke recovery therapy is developed via deep brain stimulation.
|
Detailed competitors of MicroTransponder
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microtransponder
Complete news archive for MicroTransponder
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicroTransponder
MicroTransponder was founded in 2007 and raised its 1st funding round 1 year after it was founded.
MicroTransponder is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Richard Foust is the current CEO of MicroTransponder.
MicroTransponder is a funded company, having raised a total of $180.45M across 25 funding rounds to date.
As of Dec 31, 2022, the latest employee count at MicroTransponder is 33.
MicroTransponder was founded in 2007 in Dallas, United States, as a spin-out from the University of Texas at Dallas. Medical devices in the neuroscience sector are developed, with operations centered on two neurostimulation platforms. An implanted vagus nerve stimulator is created for tinnitus treatment and post-stroke motor rehabilitation. The wireless SAINT System addresses chronic pain management. Clinical trials are planned to evaluate both platforms for neurological disorders.
MicroTransponder's top competitors include Perfuze, Conformal Medical and MIVI Neuroscience.
MicroTransponder offers Vivistim Paired VNS System.
MicroTransponder has 11 investors. Key investors include HHS, USVP, Osage University Partners, Action Potential Venture Capital, and Green Park & Golf Ventures.